We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTC icon
2001
PTC
PTC
$16B
-1,002
Closed -$203K
PTGX icon
2002
Protagonist Therapeutics
PTGX
$9.44B
-5,884
Closed -$391K
QCOM icon
2003
Qualcomm
QCOM
$176B
-2,751
Closed -$458K
QLYS icon
2004
Qualys
QLYS
$6.35B
-3,464
Closed -$458K
QNST icon
2005
QuinStreet
QNST
$1.21B
-67,906
Closed -$1.05M
QTEC icon
2006
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.83B
-1,122
Closed -$258K
QUAD icon
2007
Quad
QUAD
$525M
-49,020
Closed -$307K
RAIL icon
2008
FreightCar America
RAIL
$260M
-36,684
Closed -$359K
RAMP icon
2009
LiveRamp
RAMP
$2.3B
-35,791
Closed -$971K
RARE icon
2010
Ultragenyx Pharmaceutical
RARE
$2.55B
-22,723
Closed -$684K
RCKY icon
2011
Rocky Brands
RCKY
$369M
-12,732
Closed -$379K
RDWR icon
2012
Radware
RDWR
$1.19B
-31,129
Closed -$825K
REGN icon
2013
Regeneron Pharmaceuticals
REGN
$80.8B
-3,440
Closed -$1.93M
RERE
2014
ATRenew
RERE
$1.01B
-37,035
Closed -$170K
REX icon
2015
REX American Resources
REX
$1.41B
-17,521
Closed -$536K
RGEN icon
2016
Repligen
RGEN
$9.25B
-7,449
Closed -$996K
RGNX icon
2017
Regenxbio
RGNX
$708M
-10,348
Closed -$100K
RICK icon
2018
RCI Hospitality Holdings
RICK
$215M
-22,476
Closed -$686K
RIGL icon
2019
Rigel Pharmaceuticals
RIGL
$750M
-41,771
Closed -$1.18M
RKLB icon
2020
Rocket Lab Corp
RKLB
$51.8B
-7,264
Closed -$348K
RKT icon
2021
Rocket Companies
RKT
$38.9B
-27,674
Closed -$536K
RLAY icon
2022
Relay Therapeutics
RLAY
$4.33B
-129,422
Closed -$676K
RLJ icon
2023
RLJ Lodging Trust
RLJ
$1.69B
-120,572
Closed -$868K
RMD icon
2024
ResMed
RMD
$30.7B
-3,232
Closed -$885K
RMR icon
2025
The RMR Group
RMR
$332M
-50,901
Closed -$801K

Similar funds

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.